Life Sciences
The partners will develop a database for academics and biopharma researchers to acquire insights to help advance cancer-focused research.
The company's Precision DL speeds up screening time, enhances the image quality of PET/CT scans and improves small lesion detection.
HIMSS23
Dr. Colin Banas, chief medical officer at DrFirst, discusses how his company uses AI to automate tasks such as processing prescription refills, which prevents medication errors and reduces clinicians' administrative burden.
MJFF will use H1's AI-enabled platform to evaluate treatment approaches and improve clinical trial access for patients with Parkinson's from marginalized communities.
The Federal Trade Commission alleges the company shared personal health information with two China-based firms, Google and analytics company AppsFlyer.
Genea Biomedx will integrate AIVF's AI-enabled EMA platform into its time-lapse incubator to analyze embryo data in real time.
The company's ANNE One platform allows for wireless monitoring of neonates and infants' skin and body temperature, heart and respiratory rates, and more.
Boehringer Ingelheim and Click Therapeutics initiate clinical trial on PDTx treatment for schizophrenia and Akili's EndeavorRx shows promise for adults with ADHD.
HIMSS23
Anna Dover, director of product management at First Databank, discusses First Databank's medication decision support technology, which helps keep clinicians informed about prescription drug information without overwhelming them.
The funds will be used to expand its reach.